Study provides further evidence that immune cell dysregulation is a driver of COVID-19 severity

In one of the largest single-center COVID-19 cohort studies to date, researchers have identified a key driver of COVID-19 disease severity. The findings suggest that lung damage is linked to the loss of immune cells called macrophages that normally reside in the lung and organize tissue repair, followed by an influx of new macrophages from the blood into the lung that cause inflammation.

Source: sciencedaily.com

Related posts

Chemists produce new-to-nature enzyme containing boron

Neuropathy very common, underdiagnosed

New insight into genesis of spina bifida